Sector ratings Daiichi Sankyo Company, Limited

Equities

Market Closed - Japan Exchange Other stock markets 06:30:00 12/02/2026 GMT			5-day change	1st Jan Change
2,906.00 ^JPY	-2.60%		-0.03%	-13.20%

02-04	Daiichi Sankyo Announces First Patient Has Been Dosed in A First-In-Human Phase 1/2 Trial	CI
02-03	AstraZeneca says FDA backs Datroway, seeks more assurance on Saphnelo	AN

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI
DAIICHI SANKYO COMPANY, LIMITED	35.96B	AAA
ELI LILLY AND COMPANY	909B	A
JOHNSON & JOHNSON	580B	BBB
ABBVIE INC.	390B	AA
ROCHE HOLDING AG	370B	AA
NOVARTIS AG	305B	AAA
ASTRAZENECA PLC	314B	A
MERCK & CO., INC.	296B	A
NOVO NORDISK A/S	216B	A
AMGEN INC.	197B	A
GILEAD SCIENCES, INC.	193B	AAA
PFIZER INC.	158B	BBB
BRISTOL-MYERS SQUIBB COMPANY	122B	A
GSK PLC	118B	AA
SANOFI	118B	A
VERTEX PHARMACEUTICALS INCORPORATED	117B	AA
CHUGAI PHARMACEUTICAL CO., LTD.	96.85B	AA
TAKEDA PHARMACEUTICAL COMPANY LIMITED	57.5B	AA
JIANGSU HENGRUI PHARMACEUTICALS CO.,LTD	56.55B	AA
BAYER AG	53.77B	AA
Average	235.21B	AA
Weighted average by Cap.		AA